Dashboard
Manage Tickers

ELEVElevation Oncology, Inc.

Nasdaq elevationoncology.com


$ 3.70 $ -0.12 (-3.14 %)    

Friday, 03-May-2024 15:59:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 3.7
$ 3.98
$ 0.00 x 0
$ 0.00 x 0
$ 3.70 - $ 4.05
$ 0.36 - $ 5.89
431,646
na
175.28M
$ 240.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wedbush-reiterates-outperform-on-elevation-oncology-maintains-8-price-target
Wedbush Reiterates Outperform on Elevation...
05/03/2024 13:38:58

Wedbush analyst Robert Driscoll reiterates Elevation Oncology (NASDAQ:ELEV) with a Outperform and maintains $8 price target.

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

elevation-oncology-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q1-gaap-eps-results
Elevation Oncology shares are trading lowe...
05/02/2024 16:00:16

elevation-oncology-says-cash-cash-equivalents-and-marketable-securities-of-1041m-as-of-march-31-2024-plus-145m-in-net-proceeds-raised-under-its-atm-facility-subsequent-to-q1-of-2024-to-be-sufficient-to-fund-its-current-operations-into-2026
Elevation Oncology Says Cash, Cash Equival...
05/02/2024 12:26:15

elevation-oncology-q1-2024-gaap-eps-023-misses-020-estimate
Elevation Oncology Q1 2024 GAAP EPS $(0.23...
05/02/2024 12:24:30

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of ...

hc-wainwright--co-reiterates-buy-on-elevation-oncology-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Elev...
04/09/2024 10:21:21

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains ...

elevation-oncology-presents-preclinical-proof-of-concept-data-for-her3-adc-program-at-aacr-annual-meeting-2024
Elevation Oncology Presents Preclinical Pr...
04/08/2024 20:35:59

-- On-track to nominate development candidate in 2024 --BOSTON, April 8, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (NASDAQ:...

watching-elevation-oncology-traders-circulate-ma-blog-comments-saying-the-intensity-of-ma-interest-among-adc-developers-as-well-as-a-transactional-elev-management-team-have-made-this-company-hard-to-ignore
Watching Elevation Oncology; Traders Circu...
04/03/2024 14:10:28

Core News & Articles
HHS Says In 2025, All People With Medicare...
03/26/2024 12:54:35

https://www.hhs.gov/about/news/2024/03/26/hhs-announces-savings-41-prescription-drugs-thanks-inflation-rebates-from-biden-harri...

jmp-securities-reiterates-market-outperform-on-elevation-oncology-maintains-7-price-target
JMP Securities Reiterates Market Outperfor...
03/07/2024 15:04:19

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) with a Market Outperform and maintains $7...

wedbush-maintains-outperform-on-elevation-oncology-raises-price-target-to-8
Wedbush Maintains Outperform on Elevation ...
03/07/2024 13:16:32

Wedbush analyst Robert Driscoll maintains Elevation Oncology (NASDAQ:ELEV) with a Outperform and raises the price target fro...

hc-wainwright--co-reiterates-buy-on-elevation-oncology-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Elev...
03/07/2024 12:40:49

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains ...

recap-elevation-oncology-q4-earnings
Recap: Elevation Oncology Q4 Earnings
03/06/2024 14:00:10

elevation-oncology-q4-eps-019-beats-023-estimate-cash-cash-equivalents-and-marketable-securities-and-approximately-17m-in-net-proceeds-raised-under-its-atm-facility-is-expected-to-provide-cash-runway-into-fourth-quarter-of-2025
Elevation Oncology Q4 EPS $(0.19) Beats $(...
03/06/2024 12:36:56

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(...

elevation-oncology-to-present-preclinical-proof-of-concept-data-for-her3-adc-program-at-the-american-association-for-cancer-research-annual-meeting-2024
Elevation Oncology To Present Preclinical ...
03/05/2024 21:52:28

Data support ongoing development of antibody-drug conjugate (ADC) program targeting HER3-expressing cancers –-- On-track to nom...

jmp-securities-initiates-coverage-on-elevation-oncology-with-market-outperform-rating-announces-price-target-of-7
JMP Securities Initiates Coverage On Eleva...
03/01/2024 16:38:55

JMP Securities analyst Silvan Tuerkcan initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Market Outperform ratin...

elevation-oncology-announced-that-it-has-expanded-its-ongoing-phase-1-clinical-trial-of-eo-3021-outside-the-united-states-dosing-the-first-patient-in-japan
Elevation Oncology Announced That It Has E...
02/22/2024 12:35:30

hc-wainwright--co-maintains-buy-on-elevation-oncology-raises-price-target-to-6
HC Wainwright & Co. Maintains Buy on Eleva...
02/20/2024 12:56:04

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Elevation Oncology (NASDAQ:ELEV) with a Buy and raises the ...

how-is-the-market-feeling-about-elevation-oncology
How Is The Market Feeling About Elevation ...
01/31/2024 20:15:20

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
01/15/2024 17:30:51

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION